The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial
Open accessAbstract
BACKGROUND: Maternal obesity is associated with increased birthweight, and obesity and premature mortality in adult offspring. The mechanism by which maternal obesity leads to these outcomes is not well understood, but maternal hyperglycaemia and insulin resistance are both implicated. We aimed to establish whether the insulin sensitising drug metformin improves maternal and fetal outcomes in obese pregnant women without diabetes. METHODS: We did this randomised, double-blind, placebo-controlled trial in antenatal clinics at 15 National Health Service hospitals in the UK. Pregnant women (aged ≥16 years) between 12 and 16 weeks' gestation who had a BMI of 30 kg/m(2) or more and normal glucose tolerance were randomly assigned (1:1), via a web-based computer-generated block randomisation procedure (block size of two to four), to receive oral metformin 500 mg (increasing to a maximum of 2500 mg) or matched placebo daily from between 12 and 16 weeks' gestation until delivery of the baby. Randomisation was stratified by study site and BMI band (30-39 vs ≥40 kg/m(2)). Participants, caregivers, and study personnel were masked to treatment assignment. The primary outcome was Z score corresponding to the gestational age, parity, and sex-standardised birthweight percentile of liveborn babies delivered at 24 weeks or more of gestation. We did analysis by modified intention to treat. This trial is registered, ISRCTN number 51279843. FINDINGS: Between Feb 3, 2011, and Jan 16, 2014, inclusive, we randomly assigned 449 women to either placebo (n=223) or metformin (n=226), of whom 434 (97%) were included in the final modified intention-to-treat analysis. Mean birthweight at delivery was 3463 g (SD 660) in the placebo group and 3462 g (548) in the metformin group. The estimated effect size of metformin on the primary outcome was non-significant (adjusted mean difference -0·029, 95% CI -0·217 to 0·158; p=0·7597). The difference in the number of women reporting the combined adverse outcome of miscarriage, termination of pregnancy, stillbirth, or neonatal death in the metformin group (n=7) versus the placebo group (n=2) was not significant (odds ratio 3·60, 95% CI 0·74-17·50; p=0·11). INTERPRETATION: Metformin has no significant effect on birthweight percentile in obese pregnant women. Further follow-up of babies born to mothers in the EMPOWaR study will identify longer-term outcomes of metformin in this population; in the meantime, metformin should not be used to improve pregnancy outcomes in obese women without diabetes. FUNDING: The Efficacy and Mechanism Evaluation (EME) Programme, a Medical Research Council and National Institute for Health Research partnership.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure Trial profile *Change in eligibility from screening of notes to recruitment visit (unable to arrange recruitment visit before 16 weeks [n=26]), recruitment stopped before screening appointment (n=14), miscarriage (n=2), moved out of area (n=1), unable to provide informed consent because of difficulties with spoken English (n=5), own doctor or midwife advised against participation (n=4), duplicate note screening number issued in error (n=4). †3 months after birth.](/paper-figures/ddb4f26800dc402186a0f6627314255f/effect-of-metformin-on-maternal-and-fetal-outcomes-in-obese-pregnant-women-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the Fetal Medicine Foundation trial, women had a higher BMI (>35 kg/m2 vs. >30 kg/m2), were treated with a higher starting and maximum dose of metformin, and were more compliant than women in the EMPOWaR trial(95, 96).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [95]
In the citing paper
“By contrast, in the EMPOWaR trial, compliance was defined as ingestion of at least one tablet for at least 29% of the days between randomization and delivery, and only 67% of women fulfilled this criterion(95).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [95]
In the citing paper
“In this trial, metformin had no significant effect on birth weight, maternal weight gain during gestation, preeclampsia, or combined adverse pregnancy outcomes, including miscarriage, termination of pregnancy, or fetal or neonatal death(95).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [95]
In the citing paper
“In this trial, metformin had no significant effect on birth weight, maternal weight gain during gestation, preeclampsia, or combined adverse pregnancy outcomes, including miscarriage, termination of pregnancy, or fetal or neonatal death(95).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [95]
In the citing paper
“In the Fetal Medicine Foundation trial, women had a higher BMI (>35 kg/m2 vs. >30 kg/m2), were treated with a higher starting and maximum dose of metformin, and were more compliant than women in the EMPOWaR trial(95, 96).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [95]
In the citing paper
“In this trial, metformin had no significant effect on birth weight, maternal weight gain during gestation, preeclampsia, or combined adverse pregnancy outcomes, including miscarriage, termination of pregnancy, or fetal or neonatal death(95).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [95]
In the citing paper
“It is also noteworthy that only 13% (443/3329) of eligible patients consented to participate in the EMPOWaR study, whereas 47% (400/844) of eligible women were recruited to the Fetal Medicine Foundation study, making the latter group more representative of women who meet the study’s eligibility criteria and to whom the study’s results apply.”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [95]
In the citing paper
“In the Fetal Medicine Foundation trial, women had a higher BMI (>35 kg/m2 vs. >30 kg/m2), were treated with a higher starting and maximum dose of metformin, and were more compliant than women in the EMPOWaR trial(95, 96).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [95]
In the citing paper
“By contrast, in the EMPOWaR trial, compliance was defined as ingestion of at least one tablet for at least 29% of the days between randomization and delivery, and only 67% of women fulfilled this criterion(95).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [95]
In the citing paper
“In this trial, metformin had no significant effect on birth weight, maternal weight gain during gestation, preeclampsia, or combined adverse pregnancy outcomes, including miscarriage, termination of pregnancy, or fetal or neonatal death(95).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Boney, C. M., Verma, A., Tucker, R., & Vohr, B. R. (2005) · Pediatrics · doi:10.1542/peds.2004-1808 · Cited by 2,303
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291
Childhood predictors of adult obesity: a systematic review.
Parsons, T. J., Power, C., Logan, S., & Summerbell, C. (1999) · PubMed · Cited by 1,001
Birth Weight and Adult Hypertension, Diabetes Mellitus, and Obesity in US Men
Curhan, G. C., Willett, W. C., Rimm, E. B., Spiegelman, D. L., Ascherio, A., & Stampfer, M. J. (1996) · Circulation · doi:10.1161/01.cir.94.12.3246 · Cited by 917
Maternal Body Mass Index and the Risk of Preeclampsia: A Systematic Overview
O'Brien, T., Ray, J. G., & Chan, W. (2003) · Epidemiology · doi:10.1097/00001648-200305000-00020 · Cited by 908
Catalano, P., & Ehrenberg, H. M. (2006) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.00989.x · Cited by 828
Thangaratinam, S., Rogozinska, E., Jolly, K., Glinkowski, S., Roseboom, T., Tomlinson, J. W., Kunz, R., Mol, B. W., Coomarasamy, A., & Khan, K. S. (2012) · BMJ · doi:10.1136/bmj.e2088 · Cited by 802
Cited by
Sorted by citations
McIntyre, H. D., Catalano, P., Zhang, C., Desoye, G., Mathiesen, E. R., & Damm, P. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0098-8 · Cited by 1,850
Poon, L. C., Shennan, A. H., Hyett, J. A., Kapur, A., Hadar, E., Divakar, H., McAuliffe, F. M., Costa, F. D. S., von Dadelszen, P., McIntyre, D. H., et al. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12802 · Cited by 1,430
Stephenson, J., Heslehurst, N., Hall, J., Schoenaker, D. A. J. M., Hutchinson, J., Cade, J. E., Poston, L., Barrett, G., Crozier, S. R., Barker, M., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30311-8 · Cited by 1,222
Triangulation in aetiological epidemiology
Lawlor, D. A., Tilling, K., & Davey Smith, G. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyw314 · Cited by 1,129
Influence of Maternal Obesity on the Long-Term Health of Offspring
Godfrey, K. M., Reynolds, R. M., Prescott, S. L., Nyirenda, M., Jaddoe, V. W. V., Eriksson, J. G., & Broekman, B. F. P. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30107-3 · Cited by 1,059
Self-citationChappell, L. C., Cluver, C. A., Kingdom, J. C., & Tong, S. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32335-7 · Cited by 1,013
Koletzko, B. V., Godfrey, K. M., Poston, L., Szajewska, H., van Goudoever, J. B., de Waard, M., Brands, B. A., Grivell, R. M., Deussen, A. R., Dodd, J. M., et al. (2019) · Annals of Nutrition and Metabolism · doi:10.1159/000496471 · Cited by 445
Gestational diabetes: opportunities for improving maternal and child health
Saravanan, P., Magee, L. A., Banerjee, A., Coleman, M. A., von Dadelszen, P., Denison, F. C., Farmer, A. A., Finer, S., Fox-Rushby, J. A., Holt, R. I. G., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30161-3 · Cited by 446
Self-citationMetformin versus placebo in obese pregnant women without diabetes mellitus
Syngelaki, A., Nicolaides, K. H., Balani, J., Hyer, S., Akolekar, R., Kotecha, R., Pastides, A., & Shehata, H. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1509819 · Cited by 394
Developmental origins of health and disease: current knowledge and potential mechanisms
Hoffman, D. J., Reynolds, R. M., & Hardy, D. B. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux053 · Cited by 367
Self-citationSex and gender differences in developmental programming of metabolism
Dearden, L., Bouret, S. G., & Ozanne, S. E. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.04.007 · Cited by 353
Feig, D. S., Berger, H., Donovan, L., Godbout, A., Kader, T., Keely, E., & Sanghera, R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.038 · Cited by 344
Maternal obesity and neurodevelopmental and psychiatric disorders in offspring
Edlow, A. G. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4932 · Cited by 326
Romero, R., Erez, O., Hüttemann, M., Maymon, E., Panaitescu, B., Conde-Agudelo, A., Pacora, P., Yoon, B. H., & Grossman, L. I. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.06.003 · Cited by 253
Tarry-Adkins, J. L., Aiken, C. E., & Ozanne, S. E. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002848 · Cited by 251
Belbasis, L., Savvidou, M. D., Kanu, C., Evangelou, E., & Tzoulaki, I. (2016) · BMC Medicine · doi:10.1186/s12916-016-0692-5 · Cited by 237
Feig, D. S., Donovan, L. E., Zinman, B., Sanchez, J. J., Asztalos, E., Ryan, E. A., Fantus, I. G., Hutton, E., Armson, A. B., Lipscombe, L. L., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30310-7 · Cited by 234
Developmental origins of NAFLD: a womb with a clue
Wesolowski, S. R., Kasmi, K. C. E., Jonscher, K. R., & Friedman, J. E. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.160 · Cited by 239
Brownfoot, F. C., Hastie, R., Hannan, N. J., Cannon, P., Tuohey, L., Parry, L. J., Senadheera, S., Illanes, S. E., Kaitu’u-Lino, T. J., & Tong, S. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.12.019 · Cited by 222
Interventions to prevent maternal obesity before conception, during pregnancy, and post partum
Hanson, M. A., Barker, M. E., Dodd, J. M., Kumanyika, S., Norris, S. A., Steegers, E. A. P., Stephenson, J., Thangaratinam, S., & Yang, H. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30108-5 · Cited by 215
Hanem, L. G. E., Stridsklev, S., Júlíusson, P. B., Salvesen, Ø., Roelants, M., Carlsen, S. M., Ødegård, R., & Vanky, E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02419 · Cited by 199
Júnior, E. A., Peixoto, A. B., Zamarian, A. C. P., Elito, J., & Tonni, G. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.08.003 · Cited by 187
Løvvik, T. S., Carlsen, S. M., Salvesen, Ø., Steffensen, B., Bixo, M., Gómez-Real, F., Lønnebotn, M., Hestvold, K. V., Zabielska, R., Hirschberg, A. L., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30002-6 · Cited by 176
The Risks Associated With Obesity in Pregnancy
Stubert, J., Reister, F., Hartmann, S., & Janni, W. J. (2018) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2018.0276 · Cited by 167
Inositols: From Established Knowledge to Novel Approaches
Dinicola, S., Unfer, V., Facchinetti, F., Soulage, C. O., Greene, N. D., Bizzarri, M., Laganà, A. S., Chan, S.-Y., Bevilacqua, A., Pkhaladze, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910575 · Cited by 154
Hyperglycemia in pregnancy: prevalence, impact, and management challenges
Farrar, D. (2016) · International Journal of Women s Health · doi:10.2147/ijwh.s102117 · Cited by 133
Pregnancy Exercise and Nutrition With Smartphone Application Support: A Randomized Controlled Trial
Kennelly, M. A., Ainscough, K., Lindsay, K. L., O'Sullivan, E., Gibney, E. R., McCarthy, M., Segurado, R., DeVito, G., Maguire, O., Smith, T., et al. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002582 · Cited by 126
Sex and Gender Differences in Prevention of Type 2 Diabetes
Harreiter, J., & Kautzky‐Willer, A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00220 · Cited by 127
Gestational diabetes mellitus: does an effective prevention strategy exist?
Agha-Jaffar, R., Oliver, N. S., Johnston, D. G., & Robinson, S. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.88 · Cited by 116
Fernandez-Twinn, D. S., Gascoin, G., Musial, B., Carr, S., Duque-Guimaraes, D., Blackmore, H. L., Alfaradhi, M. Z., Loche, E., Sferruzzi-Perri, A. N., Fowden, A. L., et al. (2017) · Scientific Reports · doi:10.1038/srep44650 · Cited by 115
Risk of pre‐eclampsia in women taking metformin: a systematic review and meta‐analysis
Alqudah, A. M., McKinley, M. C., McNally, R., Graham, U. M., Watson, C. J., Lyons, T. J., & McClements, L. (2017) · Diabetic Medicine · doi:10.1111/dme.13523 · Cited by 117
Dodd, J., Louise, J., Deussen, A., Grivell, R., Dekker, G., McPhee, A., & Hague, W. (2019) · The Lancet Diabetes and Endocrinology · doi:10.1016/s2213-8587(18)30310-3 · Cited by 96
A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes
Barbour, L. A., Scifres, C., Valent, A. M., Friedman, J. E., Buchanan, T. A., Coustan, D., Aagaard, K., Thornburg, K. L., Catalano, P. M., Galan, H. L., et al. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.06.013 · Cited by 101
Crawford, T. J., Crowther, C. A., Alsweiler, J. M., & Brown, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011507.pub2 · Cited by 100
Guideline No. 391-Pregnancy and Maternal Obesity Part 1: Pre-conception and Prenatal Care
Maxwell, C., Gaudet, L., Cassir, G., Nowik, C., McLeod, N. L., Jacob, C.-É., & Walker, M. (2019) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2019.03.026 · Cited by 96
Trends in diabetes in pregnancy in Sweden 1998–2012
Fadl, H., & Simmons, D. S. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000221 · Cited by 98
Bedell, S., Hutson, J. R., de Vrijer, B., & Eastabrook, G. D. M. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161118666200616144512 · Cited by 94
Kalafat, E., Sukur, Y. E., Abdi, A., Thilaganathan, B., & Khalil, A. A. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.19084 · Cited by 92
Metformin in Pregnancy: Mechanisms and Clinical Applications
Hyer, S. L., Balani, J., & Shehata, H. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071954 · Cited by 87
White, S. L., Lawlor, D. A., Briley, A. L., Godfrey, K. M., Nelson, S. M., Oteng‐Ntim, E., Robson, S. C., Sattar, N. A., Seed, P. T., Vieira, M. C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167846 · Cited by 80
ADIPS 2020 guideline for pre‐existing diabetes and pregnancy
Rudland, V. L., Price, S., Hughes, R. C. E., Barrett, H. L., Lagstrom, J., Porter, C., Britten, F. L., Glastras, S. J., Fulcher, I., Wein, P., et al. (2020) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13265 · Cited by 85
Mone, F., Mulcahy, C., McParland, P., Breathnach, F., Downey, P., McCormack, D., Culliton, M., Stanton, A. V., Cody, F., Morrison, J. J., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-022056 · Cited by 76
Tarry‐Adkins, J. L., Ozanne, S. E., & Aiken, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-88650-5 · Cited by 69
Dodd, J. M., Grivell, R. M., Deussen, A. R., & Hague, W. M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010564.pub2 · Cited by 74
Feng, Y., & Yang, H. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2016.1228061 · Cited by 68
Metformin from mother to unborn child-are there unwarranted effects?
Nguyen, L., Chan, S.-Y., & Teo, A. K. K. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.08.047 · Cited by 67
Preeclampsia and the cardiovascular system: An update
Perry, H., Khalil, A. A., & Thilaganathan, B. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.04.009 · Cited by 66
Mills, H. L., Patel, N., White, S. L., Pasupathy, D., Briley, A. L., Ferreira, D. L. S., Seed, P. T., Nelson, S. M., Sattar, N. A., Tilling, K. M., et al. (2019) · BMC Medicine · doi:10.1186/s12916-018-1248-7 · Cited by 65
Owens, L. A., Egan, A. M., Carmody, L. A., & Dunne, F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3817 · Cited by 67
Frick, A., Syngelaki, A., Zheng, M., Poon, L. C., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.15780 · Cited by 62
Segovia, S. A., Vickers, M. H., & Reynolds, C. M. (2017) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174417000204 · Cited by 65
McIntyre, D. H., Kapur, A., Divakar, H., & Hod, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.614533 · Cited by 61
Sesmilo, G., Prats, P., Garcia, S., Rodríguez, I., Rodríguez-Melcón, A., Berges, I., & Serra, B. (2020) · Acta Diabetologica · doi:10.1007/s00592-019-01474-8 · Cited by 60
Metformin: Past, Present, and Future
Chaudhary, S., & Kulkarni, A. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01539-1 · Cited by 64
Wu, S., Jin, J., Hu, K.-L., Wu, Y., & Zhang, D. (2022) · Nutrients · doi:10.3390/nu14122383 · Cited by 64
Takele, W. W., Vesco, K. K., Josefson, J., Redman, L. M., Hannah, W., Bonham, M. P., Chen, M., Chivers, S. C., Fawcett, A. J., Grieger, J. A., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00491-1 · Cited by 55
Maric‐Bilkan, C., Abrahams, V. M., Arteaga, S. S., Bourjeily, G. R., Conrad, K. P., Catov, J. M., Costantine, M. M., Cox, B., Garovic, V. D., George, E. M., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.11644 · Cited by 57
Recurrent Gestational Diabetes Mellitus: A Narrative Review and Single-Center Experience
Egan, A. M., Enninga, E. A. L., Alrahmani, L., Weaver, A. L., Sarras, M. P., & Ruano, R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040569 · Cited by 52
Fetal Growth and Birth Anthropometrics in Metformin-Exposed Offspring Born to Mothers With PCOS
Hjorth‐Hansen, A. K., Salvesen, Ø. O., Hanem, L. G. E., Eggebø, T. M., Salvesen, K. Å., Vanky, E., & Ødegård, R. A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01191 · Cited by 49
Efficacy and safety of metformin during pregnancy: an update
Paschou, S. Α., Shalit, A., Gerontiti, E., Athanasiadou, K. I., Kalampokas, T., Ψαλτοπούλου, Θ., Lambrinoudaki, I. V., Anastasiou, E., Wolffenbuttel, B. H. R., & Goulis, D. G. (2023) · Endocrine · doi:10.1007/s12020-023-03550-0 · Cited by 49
Cluver, C. A., Walker, S. P., Mol, B. W., Hall, D. R., Hiscock, R. J., Brownfoot, F., Kaitu’u‐Lino, T. J., & Tong, S. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025809 · Cited by 48
Syngelaki, A., Campos, M. S., Roberge, S., Andrade, W. S., & Nicolaides, K. H. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1481037 · Cited by 49
Chatzakis, C., Goulis, D. G., Mareti, Ε., Eleftheriades, M. I., Zavlanos, A., Dinas, K. D., & Sotiriadis, A. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107924 · Cited by 48
Metformin for pregnancy and beyond: the pros and cons
Newman, C., & Dunne, F. (2021) · Diabetic Medicine · doi:10.1111/dme.14700 · Cited by 46
Metformin for gestational diabetes mellitus: progeny, perspective, and a personalized approach
Barbour, L. A., & Feig, D. S. (2019) · Diabetes Care · doi:10.2337/dci18-0055 · Cited by 44
Fornes, R., Simin, J., Nguyen, M. H., Cruz, G., Crisosto, N., van der Schaaf, M., Engstrand, L., & Brusselaers, N. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-00905-6 · Cited by 44
Metformin during Pregnancy: Effects on Offspring Development and Metabolic Function
Jorquera, G., Echiburú, B., Crisosto, N., Sotomayor‐Zárate, R., Maliqueo, M. A., & Cruz, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00653 · Cited by 46
López‐Hernández, Y., Oostdam, A. S. H.-V., Toro-Ortíz, J. C., López, J. A., Salgado‐Bustamante, M., Murgu, M., & Torres-Torres, L. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051186 · Cited by 41
Allotey, J., Laivuori, H. M., Snell, K. I. E., Smuk, M., Hooper, R., Chan, C. L., Ahmed, A., Chappell, L. C., von Dadelszen, P., Dodds, J. P., et al. (2020) · Health Technology Assessment · doi:10.3310/hta24720 · Cited by 43
Self-citationDoi, S. A. R., Furuya‐Kanamori, L., Toft, E., Musa, O. A. H., Islam, N., Clark, J., & Thalib, L. (2020) · Obesity Reviews · doi:10.1111/obr.12964 · Cited by 39
Lessons learned from lifestyle prevention trials in gestational diabetes mellitus
Egan, A. M., & Simmons, D. S. (2018) · Diabetic Medicine · doi:10.1111/dme.13772 · Cited by 41
MiRNAs in Gestational Diabetes Mellitus: Potential Mechanisms and Clinical Applications
Liu, Z., Jiang, Y., Liu, X.-Q., Yang, M., Chen, C., Zhao, B., Huang, H., & Luo, Q. (2021) · Journal of Diabetes Research · doi:10.1155/2021/4632745 · Cited by 39
Pregestational Diabetes in Pregnancy
Sugrue, R. P., & Zera, C. (2018) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2018.01.002 · Cited by 38
Joint impact of gestational diabetes and obesity on perinatal outcomes
Huet, J., Beucher, G., Rod, A., Morello, R., & Dreyfus, M. (2018) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2018.08.003 · Cited by 37
Progesterone Attenuates SIRT1-Deficiency-Mediated Pre-Eclampsia
Pei, J., Liu, Z., Wang, C., Chu, N., Liu, L., Tang, Y., Liu, H., Xiang, Q., Cheng, H., Li, M., et al. (2022) · Biomolecules · doi:10.3390/biom12030422 · Cited by 36
Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes
Motuhifonua, S. K., Lin, L., Alsweiler, J. M., Crawford, T. J., & Crowther, C. A. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011507.pub3 · Cited by 38
H19 lncRNA alters methylation and expression of Hnf4α in the liver of metformin-exposed fetuses
Deng, J., Mueller, M., Geng, T., Shen, Y., Liu, Y., Hou, P., Ramillapalli, R., Taylor, H. S., Paidas, M. J., & Huang, Y. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.392 · Cited by 35
Facchinetti, F., Cavalli, P., Copp, A. J., D’Anna, R., Kandaraki, E., Greene, N. D. E., Unfer, V., & for The Experts Group on Inositol in Basic and Clinical Research (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1828344 · Cited by 35
Nicholas, L. M., & Ozanne, S. E. (2019) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2018.0116 · Cited by 35
An overview of diabetes mellitus in pregnant women with obesity
Bashir, M., Fagier, Y., Ahmed, B., & Konje, J. C. (2024) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2024.102469 · Cited by 34
Schoonejans, J. M., Blackmore, H. L., Ashmore, T. J., Aiken, C., Fernandez‐Twinn, D. S., & Ozanne, S. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158104 · Cited by 36
Li, J., Leng, J., Li, W., Zhang, C., Feng, L., Wang, P., Chan, J. C. N., Hu, G., Yu, Z., & Yang, X. (2018) · Primary care diabetes · doi:10.1016/j.pcd.2018.07.010 · Cited by 33
Metformin use in obese mothers is associated with improved cardiovascular profile in the offspring
Παναγιωτοπούλου, Ό., Syngelaki, A., Georgiopoulos, G. A., Simpson, J. M., Akolekar, R., Shehata, H. A., Nicolaides, K. H., & Charakida, M. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.01.054 · Cited by 34
Metformin in Gestational Diabetes Mellitus: To Use or Not to Use, That Is the Question
Tocci, V., Mirabelli, M., Salatino, A., Sicilia, L., Giuliano, S., Brunetti, F. S., CHIEFARI, E. D., Sarro, G. D., FOTI, D. P., & Brunetti, A. (2023) · Pharmaceuticals · doi:10.3390/ph16091318 · Cited by 31
Simmons, D. S., Devlieger, R., Assche, A. V., Galjaard, S., Corcoy, R., Adelantado, J. M., Dunne, F., Desoyé, G., Kautzky‐Willer, A., Damm, P., et al. (2018) · Nutrients · doi:10.3390/nu10111568 · Cited by 31
Timms, K., Holder, B. S., Day, A., McLaughlin, J. T., Forbes, K. A., & Westwood, M. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200013 · Cited by 32
Brown adipose tissue development and function and its impact on reproduction
Symonds, M. E., Aldiss, P., Dellschaft, N. S., Law, J., Fainberg, H. P., Pope, M., Sacks, H. S., & Budge, H. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0084 · Cited by 32
Elmaraezy, A., Abushouk, A. I., Emara, A., Elshahat, O., Ahmed, H., & Mostafa, M. I. (2017) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.29252/ijrm.15.8.461 · Cited by 30
Schoonejans, J. M., Blackmore, H. L., Ashmore, T. J., Pantaleão, L. C., Pisani, L. P., Dearden, L., Tadross, J. A., Aiken, C., Fernandez‐Twinn, D. S., & Ozanne, S. E. (2022) · Diabetologia · doi:10.1007/s00125-022-05789-0 · Cited by 32
Tosti, G., Barberio, A., Tartaglione, L., Rizzi, A., Leo, M. A. S. D., Viti, L., Sirico, A., Carolis, S. D., Pontecorvi, A., Lanzone, A., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1176623 · Cited by 29
Quotah, O. F., Andreeva, D., Nowak, K. G., Dalrymple, K. V., Almubarak, A., Patel, A. N., Vyas, N. D., Çakır, G. S., Heslehurst, N., Bell, Z., et al. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01217-4 · Cited by 29
Linder, T., Eder, A., Monod, C., Rosicky, I., Eppel, D., Redling, K., Geissler, F., Huhn, E. A., Hösli, I., & Göbl, C. S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.799625 · Cited by 28
for the IPPIC Collaborative Network, Snell, K. I. E., Allotey, J., Smuk, M., Hooper, R., Chan, C., Ahmed, A., Chappell, L. C., von Dadelszen, P., Green, M., et al. (2020) · BMC Medicine · doi:10.1186/s12916-020-01766-9 · Cited by 28
Self-citationMetformin and health outcomes: An umbrella review of systematic reviews with meta‐analyses
Li, X., Celotto, S., Pizzol, D., Gašević, D., Ji, M., Barnini, T., Solmi, M., Stubbs, B., Smith, L., Sánchez, G. F. L., et al. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13536 · Cited by 27
Pascual‐Morena, C., Cavero‐Redondo, I., Álvarez‐Bueno, C., Lucerón‐Lucas‐Torres, M., Sanabria‐Martínez, G., Poyatos‐León, R., Rodríguez‐Martin, B., & Martínez‐Vizcaíno, V. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163490 · Cited by 28
Dearden, L., & Ozanne, S. E. (2023) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0222 · Cited by 26
Sciacca, L., Bianchi, C., Burlina, S., Formoso, G., Manicardi, E., Sculli, M. A., & Resi, V. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02137-5 · Cited by 28
Xu, Q., & Xie, Q. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-019-05124-w · Cited by 24
D’Ambrosio, V., Brunelli, R., Vena, F., Mascio, D. D., Marchetti, C., Boccherini, C., Piccioni, M. G., Panici, P. B., & Giancotti, A. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3164 · Cited by 24
Peleg‐Raibstein, D. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.645569 · Cited by 24
Metadata
- Authors
- Chiswick, C., Reynolds, R. M., Denison, F., Drake, A. J., Forbes, S., Newby, D. E., Walker, B. R., Quenby, S., Wray, S., Weeks, A., Lashen, H., Rodriguez, A., Murray, G., Whyte, S., & Norman, J. E.
- Affiliations
- MRC Centre for Reproductive Health (GB)
- British Heart Foundation Centre for Cardiovascular Science (GB)
- Edinburgh Royal Infirmary (GB)
- University of Warwick (GB)
- Liverpool Women's Hospital (GB)
- Jessop Hospital (GB)
- University of Edinburgh (GB)
- Corresponding author
- Norman, Jane E
- ORCID
- Venue
- The Lancet Diabetes & Endocrinology
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 3
- Issue
- 10
- Pages
- 778-786
- ISSN
- 2213-8587 (ISSN-L)
- PMC
- PMC4673088
- OpenAlex
- W2144199745
- Cited by
- 260
- References
- 36
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 15 · 2023: 21 · 2022: 21 · 2021: 27 · 2020: 28 · 2019: 28 · 2018: 33 · 2017: 22 · 2016: 27 · 2015: 6
- FWCI
- 33.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- The Lancet Diabetes & Endocrinology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Explore Bristol Research (publishedVersion)
- Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Bristol Research (University of Bristol) (submittedVersion, cc-by)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Wellcome Trust (103782)
- National Institute for Health and Care Research (08/246/09)
- Medical Research Council (MC_G1002463)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- metformin, maternal obesity, pregnancy, birth weight, insulin resistance, miscarriage, stillbirth, preterm birth, gestational diabetes mellitus, maternal hyperglycemia, placental growth factor, placental insufficiency, fetal growth restriction, placental DNA methylation, epigenetics
- MeSH terms
- Abortion, Spontaneous, Adult, Double-Blind Method, Female, Fetal Macrosomia, Humans, Hypoglycemic Agents, Metformin, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Diabetes, Gestational, Stillbirth, Young Adult, Obesity, Abdominal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
